Advanced Enzyme Technologies (BOM:540025) Equity-to-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Advanced Enzyme Technologies Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Advanced Enzyme Technologies's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₹0 Mil. Advanced Enzyme Technologies's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil.

The historical rank and industry rank for Advanced Enzyme Technologies's Equity-to-Asset or its related term are showing as below:

BOM:540025' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.41 Med: 0.84 Max: 0.88
Current: 0.87

During the past 13 years, the highest Equity to Asset Ratio of Advanced Enzyme Technologies was 0.88. The lowest was 0.41. And the median was 0.84.

BOM:540025's Equity-to-Asset is ranked better than
91.4% of 1570 companies
in the Chemicals industry
Industry Median: 0.59 vs BOM:540025: 0.87

Advanced Enzyme Technologies Equity-to-Asset Historical Data

The historical data trend for Advanced Enzyme Technologies's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Enzyme Technologies Equity-to-Asset Chart

Advanced Enzyme Technologies Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Equity-to-Asset

Get a 7-Day Free Trial

0.84

0.86

0.84

0.86

0.87

Advanced Enzyme Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Equity-to-Asset	Get a 7-Day Free Trial															-	0.87	-	0.87	-

Competitive Comparison of Advanced Enzyme Technologies's Equity-to-Asset

For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Advanced Enzyme Technologies's Equity-to-Asset Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Advanced Enzyme Technologies's Equity-to-Asset falls into.

Advanced Enzyme Technologies Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Advanced Enzyme Technologies's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	12350.69	/	14218.47
	=	0.87

Advanced Enzyme Technologies's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	0	/	0
	=

Advanced Enzyme Technologies (BOM:540025) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Advanced Enzyme Technologies Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Advanced Enzyme Technologies's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Enzyme Technologies (BOM:540025) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Advanced Enzyme Technologies Ltd (BOM:540025) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

ADVENZYMES:India

Address

Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604

Website

https://www.advancedenzymes.com

Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.

Advanced Enzyme Technologies (BOM:540025) Headlines

No Headlines